Liquid biopsy company Biocept Inc. has hired ex-Trovagene executive Michael Terry to join their leadership team as senior vice president of commercial operations.

The role is a newly created one, and responsibilities include leading the company’s commercial organization and overseeing business development.

Terry previously served as executive vice president of commercial operations and corporate development at Trovagene Inc., a San Diego-based public company that also develops liquid biopsy tests. He’s also served as executive vice president of local molecular diagnostics firm Sequenom Inc.

"We are very pleased that Mike has joined Biocept, given his significant experience in leading commercial teams and establishing disruptive technologies in the healthcare segment,” said Biocept’s president and CEO Michael Nall in a statement. “He has served in both large and small diagnostic and medical technology companies, which will be key to facilitating our growth.”

Biocept, which has a market cap of $35.4 million, develops commercial diagnostic tests for several types of cancer.